British Journal of Clinical Pharmacology, 50(5), 415-420
GLP-1 receptor agonists function by: Stimulating insulin release when blood sugar levels are high Reducing glucagon secretion, which helps lower blood sugar Slowing gastric emptying, leading to increased satiety Affecting appetite centers in the brain, reducing food intake While these mechanisms contribute to the drugs effectiveness, they may also play a role in potential side effects, including the rare but serious risk of NAION
Those in the semaglutide group reduced their waist circumference 7.7 cm at 4 years
WADAs Summary of Major Modifications and Explanatory Notes is available and weve explained the major changes, as well as some of the minor clarifications, below
Mounjaro has a similar side effect profile, but its list of serious side effects also includes severe stomach problems, according to Eli Lilly